Uneek Mehra - 15 Sep 2021 Form 4 Insider Report for Myovant Sciences Ltd.

Role: Principal Financial Officer
Signature: /s/ Matthew Lang, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 15 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 17 Sep 2021, 16:31:00 UTC
Previous filing: 09 Sep 2021
Next filing: 19 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYOV	Common Shares	Award	$0	+103,069		$0.000000	103,069	15 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MYOV	Stock Options (Right to Buy)	Award	$0	+165,192		$0.000000	165,192	15 Sep 2021	Common Shares	165,192	$21.83	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units ("RSUs") granted to the Reporting Person. 1/4 of the Common Shares underlying the RSUs vest on September 15, 2022, and 1/16 of the Common Shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
F2	1/4 of the Common Shares underlying this option vest on September 15, 2022, and 1/16 of the Common Shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.